Showing results (191-200 of 415) with videos related to

Sort By:
Pageof 42
Journal of Hepatology|July 19, 2022
Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinionGeorge V Papatheodoridis, Vasileios Lekakis, Thodoris Voulgaris, et al.
Expert Opinion on Drug Safety|September 5, 2012
Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studiesPatrick Marcellin, Stuart K Roberts, K Rajender Reddy, et al.
Journal of Clinical and Experimental Hepatology|July 14, 2020
Predictors, Presentation, and Treatment Outcomes of Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Large Single Center ExperienceSirina Ekpanyapong, Neil Philips, Bao-Li Loza, et al.
The American Journal of Gastroenterology|January 6, 2025
The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory AscitesFlorence Wong, Hugo E Vagas, K Rajender Reddy, et al.
Hepatology Communications|April 6, 2018
Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohortPaul Kwo, Michael W Fried, K Rajender Reddy, et al.
Hepatology Communications|May 22, 2026
Midodrine versus placebo in patients with acute-on-chronic liver failure with ascites-A randomized trial (MIDAS trial)Anand V Kulkarni, Shantan Venishetty, Sridevi Prasanna, et al.
The American Journal of Gastroenterology|August 23, 2002
Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver diseaseGuy W Neff, Christopher B O'Brien, K Rajender Reddy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 29, 2016
Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis CNiharika Samala, Elizabeth C Wright, A Gretchen Buckler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019Elizabeth C Verna, Charles Landis, Robert S Brown, et al.
The American Journal of Gastroenterology|September 9, 2015
Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injuryRobert J Fontana, Paul H Hayashi, Huiman Barnhart, et al.
Pageof 42